Search for: "Forbes v. State of Georgia*" Results 41 - 58 of 58
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
17 Apr 2023, 5:50 am by INFORRM
The Independent, Forbes and Reuters covered the privacy breach. [read post]
4 May 2014, 10:16 am by Kelly Phillips Erb
It already has an impressive television and film resume including Breakfast at Tiffany’s, The Godfather, Ghostbusters, Big, Kramer v. [read post]
31 Jul 2023, 2:23 am by INFORRM
The Guardian, Forbes, BBC and Sky News have more information. [read post]
15 Nov 2020, 4:25 pm by INFORRM
Surveillance There was a piece on Forbes “Revealed: How The EU Funds Global iPhone And Facebook Surveillance”. [read post]
23 Mar 2015, 7:31 am by Venkat Balasubramani
The “public concern” test from employment cases is a poor fit for the reasons stated by the dissent. [read post]
23 Sep 2015, 7:43 am by Kevin Smith, J.D.
The connection with Georgia State is mostly found in the fact that the opinion in Katz v. [read post]
1 Sep 2012, 3:10 pm by Russell Beck
Nevada: The United States District Court for the District of Nevada held in Switch Communications Group v. [read post]
8 Apr 2013, 2:29 pm by Ken
Hr’g Tr., Sunlust Pictures, LLC v. [read post]
12 Nov 2007, 7:50 am
Cystic Fibrosis Chapter 6917 Arlington Road, Suite 308 Bethesda, MD 20814 Phone: (301) 657-8444; (877) 657-8444 (Toll Free) Fax: (301) 652-9571 E-mail: metro-dc@cff.org Web: http://www.cff.orgmetrodc.htm Developmental Disabilities State Developmental Disabilities Planning Council MD Developmental Disabilities Council 300 West Lexington Street, Box 10 Baltimore, MD 21201-2323 Phone: (410) 333-3688 (V/TTY); (800) 305-6441 (Toll Free in MD only) E-mail: info@md-council.org Web:… [read post]
22 Mar 2008, 2:00 am
: (IPBiz),US: Two remaining challenged WARF embryonic stem cell patents upheld in ex parte reexamination: (Holman's Biotech IP Blog), Pharma & Biotech - ProductsAricept (Donepezil) – USV wins appeal against USPTO decision: (Spicy IP),Celerex (Celecoxib) – CAFC decision in Celebrex patents dispute between Pfizer and Teva will cut patent term by one and a half years: (Patent Baristas), Inersan – Ranbaxy in-licenses Inersan to CD Pharma to market in India and… [read post]
27 Apr 2020, 3:00 am by Joshua Holt
His high-profile cases include the “trial of the century,” otherwise known as United States v. [read post]
31 Jan 2010, 7:16 pm by admin
. - Kelsey Swanekamp, Forbes, January 25, 2010 Westar Energy will devote $500 million to cut air pollution from one of its Kansas plants as part of a settlement of a Clean Air Act violation lawsuit. [read post]
28 Apr 2022, 9:01 pm by Caroline A. Crenshaw
Thank you Hal [Scott] for that kind introduction and for inviting me to speak today. [read post]